Abstract
Supporting Institution
yok
References
- Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imag 2020; 66: 35–41.
- Vishwajeet V, Krishna H, Ghatak S, Elhence PA, Ambwani S, Varthya SB. Renal histopathological changes in coronavirus disease 2019 patients: a systematic review and meta-analysis of individual patient data. Saudi J Kidney Dis Transplant 2021; 32: 1523–42.
- Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 2020; 126: 1456–74.
- Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ van, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol A J Pathol Soc Gt Britain Irel 2004; 203: 631–7.
- Eckerle I, Müller MA, Kallies S, Gotthardt DN, Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol J 2013; 10: 1–5.
- Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med 2020; 52: 345–53.
- Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Physiol 2020; 318: 1454–62.
- Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; 97: 829–38.
- Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol 2020; 16: 308–10.
- Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020; 98: 219–27.
- Pan X, Xu D, Zhang H, Zhou W, Wang L, Cui X. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020; 46: 1114–6.
- Hirsch JS, Ng JH, Ross DW,et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020; 9: 209–18.
- Huang Q, Li J, Lyu S, et al. COVID-19 associated kidney impairment in adult: Qualitative and quantitative analyses with non-enhanced CT on admission. Eur J Radiol 2020; 131: 109240.
- Goldman SM, Faintuch S, Ajzen SA, et al. Diagnostic Value of Attenuation Measurements of the Kidney on Unenhanced Helical CT of Obstructive Ureterolithiasis. Am J Roentgenol 2004; 182: 1251–4.
- Pan F, Ye T, Sun P, Gui S, Liang B, Li L. Time course of lung changes at chest CT during Recovery. Radiology 2020; 295: 715–21.
- Zhou S, Chen C, Hu Y, Lv W, Ai T, Xia L. Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19. Ann Transl Med 2020: 8: 1449.
- Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol 2020; 30: 6808–17.
- Li Z, Wu M, Yao J, et al. Caution on kidney dysfunctions of COVID-19 patients. SSRN Electron J 2020; 1–25.
- Martinez-Rojas MA, Vega-Vega O, Bobadilla XNA. Is the kidney a target of SARS-CoV-2? Am J Physiol - Ren Physiol 2020; 318: 1454–62.
- Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020; 14: 185–92.
- Hamming I, Timens W, Bulthuis M, Lely AT, Navis GJ, Van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Wiley Online Libr 2004; 203: 631–7.
- Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 2021; 12: 2506.
- Papadimitriou JC, Drachenberg CB, Kleiner D, Choudhri N, Haririan A, Cebotaru V. Tubular Epithelial and Peritubular Capillary Endothelial Injury in COVID-19 AKI. Kidney Int Rep. 2021; 6: 518-25.
- Adamczak M, Surma S, Wiecek A. Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment. Adv Clin Exp Med 2022; 31: 317–26.
- Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet 2020; 395: 1014-5.
- Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014; 371: 58–66.
- Stunell H, Buckley O, Feeney J, Geoghegan T, Browne RFJ, Torreggiani WC. Imaging of acute pyelonephritis in the adult. Eur Radiol 2007; 17: 1820–8.
Correlations of renal parenchymal attenuations and CT severity scores on three consecutive CTs in COVID-19 patients
Abstract
Aim: We aimed to investigate the correlation between the temporal changes of computed tomography severity score (CT-SS) and mean renal parenchymal attenuation (MRPA) values in consecutive chest computed topographies (CT).
Material and Method: This retrospective, single-center study included 65 (≥18 years) COVID-19 patients with positive RT-PCR tests. A radiologist calculated three consecutive chest CT-SSs and measured the MPRAs on CTs from the upper half of each kidney included in the cross-section. Paired samples test and Wilcoxon signed-rank test were used to evaluate the temporal changes of mean renal parenchymal attenuation (RPA) and median CT-SS values, in three consecutive CTs. Spearman's test was used to evaluate the correlation of each RPA and CT-SS value on three consecutive CTs.
Results: The study population included 65 patients with a mean age of 61.49±13.91 years. A total of 36/65 (55.4%) were male. We found a significant increase between the first and second CT-SS (p<0.001) values, and a significant decrease between the first and second RPA (p<0.001) values. There were statistically significant moderate negative linear correlations between MRPA values and consecutive CT-SSs in COVID-19 patients (correlation coefficient [r]1=-0.320, p=0.009; r2=-0.381, p=0.002; r3=-0.393, p=0.001).
Conclusion: The decrease in renal parenchymal attenuation in non-enhanced computed tomography is related to the severity of pneumonia in COVID-19 patients and may be an attention factor for acute kidney injury.
References
- Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imag 2020; 66: 35–41.
- Vishwajeet V, Krishna H, Ghatak S, Elhence PA, Ambwani S, Varthya SB. Renal histopathological changes in coronavirus disease 2019 patients: a systematic review and meta-analysis of individual patient data. Saudi J Kidney Dis Transplant 2021; 32: 1523–42.
- Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 2020; 126: 1456–74.
- Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ van, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol A J Pathol Soc Gt Britain Irel 2004; 203: 631–7.
- Eckerle I, Müller MA, Kallies S, Gotthardt DN, Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol J 2013; 10: 1–5.
- Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med 2020; 52: 345–53.
- Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Physiol 2020; 318: 1454–62.
- Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; 97: 829–38.
- Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol 2020; 16: 308–10.
- Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020; 98: 219–27.
- Pan X, Xu D, Zhang H, Zhou W, Wang L, Cui X. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020; 46: 1114–6.
- Hirsch JS, Ng JH, Ross DW,et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020; 9: 209–18.
- Huang Q, Li J, Lyu S, et al. COVID-19 associated kidney impairment in adult: Qualitative and quantitative analyses with non-enhanced CT on admission. Eur J Radiol 2020; 131: 109240.
- Goldman SM, Faintuch S, Ajzen SA, et al. Diagnostic Value of Attenuation Measurements of the Kidney on Unenhanced Helical CT of Obstructive Ureterolithiasis. Am J Roentgenol 2004; 182: 1251–4.
- Pan F, Ye T, Sun P, Gui S, Liang B, Li L. Time course of lung changes at chest CT during Recovery. Radiology 2020; 295: 715–21.
- Zhou S, Chen C, Hu Y, Lv W, Ai T, Xia L. Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19. Ann Transl Med 2020: 8: 1449.
- Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol 2020; 30: 6808–17.
- Li Z, Wu M, Yao J, et al. Caution on kidney dysfunctions of COVID-19 patients. SSRN Electron J 2020; 1–25.
- Martinez-Rojas MA, Vega-Vega O, Bobadilla XNA. Is the kidney a target of SARS-CoV-2? Am J Physiol - Ren Physiol 2020; 318: 1454–62.
- Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020; 14: 185–92.
- Hamming I, Timens W, Bulthuis M, Lely AT, Navis GJ, Van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Wiley Online Libr 2004; 203: 631–7.
- Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 2021; 12: 2506.
- Papadimitriou JC, Drachenberg CB, Kleiner D, Choudhri N, Haririan A, Cebotaru V. Tubular Epithelial and Peritubular Capillary Endothelial Injury in COVID-19 AKI. Kidney Int Rep. 2021; 6: 518-25.
- Adamczak M, Surma S, Wiecek A. Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment. Adv Clin Exp Med 2022; 31: 317–26.
- Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet 2020; 395: 1014-5.
- Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014; 371: 58–66.
- Stunell H, Buckley O, Feeney J, Geoghegan T, Browne RFJ, Torreggiani WC. Imaging of acute pyelonephritis in the adult. Eur Radiol 2007; 17: 1820–8.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | March 27, 2023 |
| Published in Issue | Year 2023 Volume: 6 Issue: 2 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.